Biocryst outlines $415M-$425M 2026 operating expense guidance while keeping ORLADEYO at $625M-$645M
We haven't written up this one. Seeking Alpha News has the full story — the link below goes straight to it.
What's breaking now, across thousands of outlets.
We haven't written up this one. Seeking Alpha News has the full story — the link below goes straight to it.
